Pharming Group (PHGUF) Stock Statistics & Valuation Metrics

Pharming Group has a market cap or net worth of $928.61M. The enterprise value is $633.89M.

Pharming Group has 685,147,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharming Group’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -1.39%.

The current PE Ratio of Pharming Group is ―. Pharming Group’s PEG ratio is ―.

In the last 12 months, Pharming Group had revenue of 286.89M and earned -10.64M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was 31.05M and capital expenditures -918.00K, giving a free cash flow of 30.13M billion.

Pharming Group pays an annual dividend of ―, resulting in a dividend yield of ―

Pharming Group upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).

Pharming Group as a current ratio of 3.65, with Debt / Equity ratio of 53.57%

In the past 12 months, Pharming Group has paid 2.43M in taxes.

Pharming Group EV to EBITDA ratio is 52.58, with an EV/FCF ratio of -277.67.

Pharming Group has $126.01M in cash and marketable securities with $128.33M in debt, giving a net cash position of $2.32M billion.

Gross margin is 89.31%, with operating margin of -1.18%, and net profit margin of -3.71%.

The average price target for Pharming Group is $2.85, which is 11.43% higher than the current price. The consensus rating is Moderate Buy